Early intervention through pharmacological treatment of impaired glucose tolerance (IGT) individuals at high risk of type 2 diabetes with oral antidiabetic agents that improve insulin sensitivity and preserve β-cell function have also been shown to reduce the progression of IGT to type 2 diabetes by 50–70% [7]. Here, INS is linked to type 2 diabetes mellitus.